You are here: Industry Insights > COVID-19

News List

NIH begins large clinical trial to test immune modulators for treatment of COVID-19 worldpharmanews
October 21, 2020
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
CQC assessment is a ‘wake-up call’ to government, says NHS Confed chief exec pharmatimes
October 19, 2020
The Care Quality Commission (CQC) has published its annual State of Care assessment of health and social care in England, finding that the care people received in 2019/20 was mostly of good quality.
Novellus Licenses Induced Mesenchymal Stem Cells to NoveCite for COVID-19 Related ARDS americanpharmaceuticalreview
October 19, 2020
Novellus Therapeutics has licensed its induced mesenchymal stem cells (iMSCs) on a worldwide basis to NoveCite, a newly formed subsidiary of Citius Pharmaceuticals.
BioGX Announces EUA Submission of Extraction-Free Direct RT-PCR Test for COVID-19 americanpharmaceuticalreview
October 19, 2020
BioGX announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
NeuroRx, Relief Releases RLF-100 Data for COVID-19 Respiratory Failure americanpharmaceuticalreview
October 19, 2020
Relief Therapeutics and NeuroRx has announced topline results from 45 patients assessed in an open-label prospective study where 21 patients admitted to an intensive care unit (ICU) with critical COVID-19 and respiratory failure were treated with ...
Vaccine trials outside home market will help Chinese firms capture Asia, South and Central America markets: GlobalData expresspharma
October 19, 2020
Pharma companies across the globe are working to develop a vaccine against COVID-19, which has already infected more than 38 million globally.
Remdesivir price curbs in India make COVID-19 treatment more affordable: GlobalData expresspharma
October 19, 2020
Maharashtra has fixed the price of remdesivir at Rs 2,360, 16 per cent more economical than the cheapest brand Remdac at Rs 2,800 by Zydus Cadila and 56 per cent more economical than Covifor at Rs 5,400 by Hetero Labs.
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V in India expresspharma
October 19, 2020
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study.
Biopharma companies more optimistic about 2020 imports/exports than in Q1: GlobalData expresspharma
October 19, 2020
API manufacturing still remains a greater concern than finished dose due to the high volume of small molecule API produced in China and India for cost reasons.
Vaccine delivery system should involve all levels of governments and citizen groups: PM Modi expresspharma
October 19, 2020
He stressed that every step in the logistics, delivery, and administration should be put in place rigorously.